Food News and Research

RSS

Evaluation method supports soy as high-quality protein

The importance of protein in the human body is undeniable. However, the idea of what makes a protein a "quality protein" has not been as easy to determine. A new study from the Journal of Agriculture and Food Chemistry takes a closer look at the criteria for determining the quality of a protein.

7 Dec 2011

First international agricultural communications symposium to be held on Feb. 17 at U of I

Is it possible to find common ground among colliding beliefs surrounding food and agriculture? Food security is one of the most pressing issues facing world leaders today, and despite the technological tools available to help more of the world's population reach self-sufficiency, an epic communications challenge remains.

7 Dec 2011

Donated permanent pacemakers safe and effective for Indian heart patients

Many heart patients in India are too poor to afford pacemakers. But a study has found that removing pacemakers from deceased Americans, resterilizing the devices and implanting them in Indian patients "is very safe and effective."

From Medtronic 7 Dec 2011

FDA modifies requirements of Amgen's Nplate REMS Program

Amgen today announced the U.S. Food and Drug Administration (FDA) has modified the requirements of the Nplate (romiplostim) Risk Evaluation and Mitigation Strategy (REMS) Program.

7 Dec 2011

Milk powder outperforms lower-dose therapy for treatment of food allergies

A small study by researchers at the Johns Hopkins Children's Center and Duke University shows that eating higher doses of milk protein in the form of dry powder substantially outperforms lower-dose therapy — a few drops of liquid milk extract under the tongue — for treatment of food allergies.

7 Dec 2011

Hormone-blocking therapy for prostate cancer does not raise risk of heart attacks

Hormone-blocking therapy for prostate cancer doesn't raise the risk of fatal heart attacks - as some recent studies had suggested - according to a new report from Dana-Farber/Brigham and Women's Cancer Center.

7 Dec 2011

Purdue, GE Healthcare and Notre Dame announce commercial availability of Veo CT scan

Demonstrating their shared legacy of innovative research and commitment to patient-centered medical technology, the University of Notre Dame, Purdue University and GE Healthcare have announced the commercial availability of a new CT scanning technology, called Veo-, that enables physicians to diagnose patients with high clarity images at previously-unattainable low radiation dose levels.

7 Dec 2011

INT-777 shows promise against metabolic syndrome

Heart disease is a major cause of death in industrialised countries, and is strongly associated with obesity and diabetes. Many scientists believe that what links these conditions is a chronic, low-grade inflammation.

7 Dec 2011

Obese, overweight people at increased risk of cancer

More than a quarter of obese and overweight people do not want to lose weight and many more are unaware of the benefits brought by a healthy lifestyle, a new survey by Cancer Research UK reveals..

7 Dec 2011

PDUFA goal date of NDA for Protalix's taliglucerase alfa extended

Protalix BioTherapeutics, Inc., announced today that it received notification from the U.S. Food and Drug Administration (FDA) that the FDA has extended the Prescription Drug User Fee Act (PDUFA) goal date of the New Drug Application (NDA) for taliglucerase alfa to May 1, 2012, a three-month extension from the previous PDUFA date of February 1, 2012.

6 Dec 2011

Endocrine Society supports policies that aim to combat pediatric obesity

Today, The Endocrine Society issued a Position Statement supporting policies that bring together doctors and other healthcare providers, family, schools and the community to combat pediatric obesity through education and encouragement of lifestyle modifications.

6 Dec 2011

Fruit fly and malaria mosquito sensors attuned to heat, chemical odors

Fruit flies and mosquitoes share similar sensory receptors that allow them to distinguish among thousands of sensory cues - particularly heat and chemical odors - as they search for food or try to avoid danger, researchers from Boston College and Brandeis University report in the current electronic edition of the journal Nature.

6 Dec 2011

FDA assigns CTIs' pixantrone NDA new PDUFA action date

Cell Therapeutics, Inc. today announced that the U.S. Food and Drug Administration's Division of Oncology Products 1 has notified CTI that CTI's October 2011 resubmitted New Drug Application is considered a complete, Class 2 response to the FDA's April 2010 complete response letter.

6 Dec 2011

EMBL-EBI, BBSRC welcome UK funding announcement on behalf of life science community

The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) and the Biotechnology and Biological Sciences Research Council (BBSRC) warmly welcome today's announcement from the UK Government of a £75 million commitment from the Department for Business, Innovation and Skills' Large Facilities Capital Fund (LFCF) for the ELIXIR research infrastructure.

6 Dec 2011

Cameron says all NHS patients should share their medical data for research

According to British Prime Minister David Cameron, every NHS patient should be a “research patient” with their medical details “opened up” to private healthcare firms. The PM announced that all those who use the NHS in England will be helping in the fight against disease by helping advance research. He hopes the result will be that patients get faster access to new treatments and Britain's life sciences sector will become a world leader.

6 Dec 2011

Converting patients to lamotrigine extended-release for epilepsy treatment found effective and safe

Epilepsy drug-switching study shows that using more ethical control groups could be the way forward for testing both drug efficacy and safety

5 Dec 2011

InfraReDx receives $10M senior secured multi-draw term loan from GE Capital

GE Capital, Healthcare Financial Services announced today that it was the sole lender on a $10 million senior secured multi-draw term loan to InfraReDx, Inc., a medical device company committed to advancing the diagnosis and management of coronary artery and other vascular diseases. The financing will be used to help support product commercialization efforts.

5 Dec 2011

Spectrum seeks FDA IND approval for SPI-014 to treat hyperphosphatemia

Spectrum Pharmaceuticals today announced that it has submitted an investigational new drug (IND) application to the U.S. Food & Drug Administration for SPI-014 (previously referred to as RENAZORB), a second-generation lanthanum-based nanoparticle phosphate binding agent, that has the potential to treat hyperphosphatemia in patients with Stage 5 chronic kidney disease, or end-stage renal disease (ESRD).

5 Dec 2011

Subconscious nervous impulses may be prognostic markers for weight-loss outcome

A recent study of obese volunteers participating in a 12-week dietary weight-loss program found that successful weight losers had significantly higher resting nerve activity compared to weight-loss resistant individuals.

5 Dec 2011

Post-baseline vision data from Lundbeck's Sabril patient registry presented at AES meeting

Post-baseline vision data from Lundbeck's Sabril patient registry is available for the first time today as a late-breaking poster presentation at the annual meeting of the American Epilepsy Society.

5 Dec 2011